Tata Chemicals Limited — Board Meeting, 04-05-2026: Outcome of Board Meeting

Tata Chemicals' board approved Q4 & FY26 consolidated financial results, reporting a loss primarily due to a ₹1,837 Cr goodwill impairment in US operations. A ₹11/share dividend for FY26 was declared, pending shareholder nod.